Home » Topics » BioWorld

BioWorld
RSS

SYNTRO-HOECHST ANIMAL VACCINE DEAL

Feb. 20, 1992

IVAX UNIT BEGINS ALZHEIMER'S TRIALS

Feb. 20, 1992

CHIMP STILL FREE OF AIDS INFECTION

Feb. 20, 1992

WALL ST. VENTS FRUSTRATION AT CENTOCOR

Feb. 20, 1992

EPITOPE TOLD TO EXPAND DISEASE TARGETS

Feb. 20, 1992

SANDOZ COMPLETES SYSTEMIX TENDER OFFER

Feb. 20, 1992

TAXOL MAKER CLOSES PRIVATE PLACEMENT

Feb. 20, 1992

PARKINSON'S TREATMENT DISAPPOINTING

Feb. 20, 1992

AMYLIN SPEEDS UP TRIAL PLANS

Feb. 19, 1992

NVX VACCINE DEAL WITH DANES

Feb. 19, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.